LIMS Integration — Programmable Bio

Section 07

LIMS Integration — The Quiet Wedge

LIMS (Laboratory Information Management Systems) is where the lab's institutional memory lives. STARLIMS, LabWare, LabVantage, Benchling, SampleManager — every serious lab has one, and most are 10–20 years old, painful to extend, and unloved. LabOS being LIMS-native is the quiet wedge that converts a "platform sale" into an "infrastructure upgrade." Buyers approve infrastructure upgrades. Buyers stall on platform sales.

Why LIMS is the wedge

Already budgeted: labs spend $50K–$500K/year per site on LIMS. We replace or augment that line item — no net-new budget required.
Audit-trail mandate: 21 CFR Part 11, GxP, NABL — LIMS exists because regulators demand provenance. Our provenance-signed graph natively satisfies the same audit requirements, often better.
Switching cost is the moat: once we are the system of record for sample lineage and experiment state, displacing us means re-validating every protocol. Same dynamic that protects incumbents — flipped to favor us.
Sample lineage = data lineage: sample tracking is the exact same graph as experimental provenance. We unify two systems that have always been separate.

Integration architecture

Three integration tiers

Tier 1 — Sidecar (Months 0–6): Read-only adapters for STARLIMS, LabWare, LabVantage, Benchling. LabOS reads sample IDs, writes back results + provenance. Customer's existing LIMS stays canonical. Zero validation burden.

Tier 2 — Bidirectional sync (Months 6–18): Two-way integration with conflict resolution. Sample lineage authoritative in LabOS; LIMS gets the human-readable view. Sample management moves into the agent mesh.

Tier 3 — LIMS replacement (Year 2+): For new sites and greenfield CROs, LabOS-native LIMS as a module. Sells as "LabOS Bench" — modern UX, agent-driven, on top of the same graph.

Targeted LIMS / ELN ecosystem

System	Footprint	Integration priority	Year 1 target
Benchling	Biotech / academic / startup-favored ELN+LIMS	P0 (modern API, ecosystem)	Native two-way sync
STARLIMS (Abbott)	Pharma QC, Indian generic pharma	P0 (Sun, Dr Reddy's, Cipla footprint)	Tier-1 sidecar
LabWare	Large pharma R&D, Apollo Diagnostics likely	P0 (Apollo integration path)	Tier-1 sidecar
LabVantage	Mid-large pharma, biopharma	P1	Tier-1 sidecar Q4
SampleManager (Thermo)	Analytical labs, Thermo instrument shops	P1	Q4 connector
SapioSciences, Genemod, eLabNext	Modern challengers	P2	Year 2 if pulled by customer

The LIMS narrative for pharma BD

"You will not replace your STARLIMS deployment. LabOS sits beside it, gives your scientists agentic experiment design and your QA team better audit trails, and within a year your sample lineage is more searchable than it has ever been. No validation re-cert. No data migration. One signed MSA."